VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 42 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $692,783 | +23.1% | 95,032 | 0.0% | 0.00% | – |
| Q1 2024 | $562,589 | -19.1% | 95,032 | 0.0% | 0.00% | – |
| Q4 2023 | $695,634 | +88.4% | 95,032 | 0.0% | 0.00% | – |
| Q3 2023 | $369,199 | -32.7% | 95,032 | 0.0% | 0.00% | – |
| Q2 2023 | $548,335 | +98.0% | 95,032 | +189.8% | 0.00% | – |
| Q1 2022 | $277,000 | -6.7% | 32,788 | 0.0% | 0.00% | – |
| Q4 2021 | $297,000 | -25.6% | 32,788 | 0.0% | 0.00% | – |
| Q3 2021 | $399,000 | +7.5% | 32,788 | 0.0% | 0.00% | – |
| Q2 2021 | $371,000 | -25.4% | 32,788 | 0.0% | 0.00% | – |
| Q1 2021 | $497,000 | -8.3% | 32,788 | -30.3% | 0.00% | – |
| Q4 2020 | $542,000 | +51.4% | 47,054 | +1.7% | 0.00% | – |
| Q3 2020 | $358,000 | -23.2% | 46,263 | +9.4% | 0.00% | – |
| Q2 2020 | $466,000 | -15.3% | 42,307 | -16.0% | 0.00% | – |
| Q1 2020 | $550,000 | -25.2% | 50,373 | +8.9% | 0.00% | – |
| Q4 2019 | $735,000 | +13.8% | 46,265 | +5.7% | 0.00% | – |
| Q3 2019 | $646,000 | +178.4% | 43,755 | +118.9% | 0.00% | – |
| Q2 2019 | $232,000 | – | 19,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Propel Bio Management, LLC | 424,937 | $3,097,791 | 2.01% |
| Perceptive Advisors | 7,099,182 | $51,753,037 | 1.25% |
| BML Capital Management, LLC | 180,000 | $1,312,200 | 0.94% |
| Avoro Capital Advisors LLC | 3,999,999 | $29,159,993 | 0.39% |
| Simplify Asset Management Inc. | 280,000 | $2,041,200 | 0.14% |
| EAM Investors, LLC | 70,586 | $514,572 | 0.08% |
| SteelPeak Wealth, LLC | 122,836 | $895,475 | 0.04% |
| SPC Financial, Inc. | 30,000 | $218,700 | 0.02% |
| Key FInancial Inc | 9,415 | $68,635 | 0.02% |
| Miracle Mile Advisors, LLC | 84,000 | $612,360 | 0.02% |